Effectiveness of MORA electronic homeopathic copies of remedies for allergic rhinitis: A short-term, randomized, placebo-controlled PILOT study

Abstract

BackgroundUpon review of the literature, much work has been done to improve the safety and efficacy of immunotherapy. ObjectiveThis study's aim was to evaluate the effectiveness and safety of using MORA bioresonance electronic homeopathic copies of remedies in the treatment of allergic rhinitis. MethodsThirty-six newly diagnosed allergic rhinitis patients (aged 6–63 years) participated in this study. Corticosteroid washout period including intranasal and inhaled form was set for one month. They were randomly assigned to a study group (n=23) and an allergic control group (n=13). During the first 4 weeks, only the study group was given electronic homeopathic copies therapy, after which both groups were treated with electronic homeopathic copies during the subsequent 4 weeks. Mite-specific IgE, -IgG4, and -IgG4/IgE ratios were evaluated and total nasal symptom scores and nose running scores were evaluated. ResultsAll 36 patients completed the study program. Study group patients had lower nose running scores after 4 weeks of treatment and nose running scores and Dermatophagoides pteronyssinus (Der p)-specific IgG4 levels between the 2 groups were significantly different after 8 weeks of electronic homeopathic copies therapy. Also, total nasal symptom scores, nose running scores, and Der p-specific IgE, -specific IgG4, and the IgG4/IgE ratio were significantly different between 4 and 8 weeks of treatment. Patients tolerated the electronic homeopathic copies treatment well and no adverse reactions were observed. ConclusionOur results suggest that MORA homeopathic remedies copies is an effective therapy for allergic rhinitis, although larger group, longer-term studies should be performed.